Top Markets
Coin of the day
BioMark Diagnostics Inc. BioMark Diagnostics Inc.

BioMark Diagnostics Inc.

BUX
株式のランク #26215
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
株価
$0.37430781
時価総額
$39.34M
変化(1日)
-12.07%
変化(1年)
48.36%
CA
取引 BioMark Diagnostics Inc. (BUX)

カテゴリー

BioMark Diagnostics Inc.(BUX)のP/B比率
2026 時点のP/B比率 TTM: 0
BioMark Diagnostics Inc. の最新の財務報告および株価によると、現在のP/B比率(TTM)は 0 です。2026 年末時点でのP/B比率は 0 でした。
BioMark Diagnostics Inc. の P/B 比率の履歴(2026 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
5.9029 -
US